The binding of a nitroxide spin-labeled analog of N-acetyllactosamine to ga
lectin-3, a mammalian lectin of 26 kD size, is studied to map the binding s
ites of this small oligosaccharide on the protein surface. Perturbation of
intensities of cross-peaks in the N-15 heteronuclear single quantum coheren
ce (HSQC) spectrum of full-length galectin-3 owing to the bound spin label
is used qualitatively to identify protein residues proximate to the binding
site for N-acetyllactosamine. A protocol for converting intensity measurem
ents to a more quantitative determination of distances between discrete pro
tein amide protons and the bound spin label is then described. This protoco
l is discussed as part of a drug design strategy in which subsequent pertur
bation of chemical shifts of distance mapped amide cross-peaks can be used
effectively to screen a library of compounds for other ligands that bind to
the target protein at distances suitable for chemical linkage to the prima
ry ligand. This approach is novel in that it bypasses the need for structur
e determination and resonance assignment of the target protein.